Skip to content

Clinical trials

Expanded access trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: Japan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

No trials to chart.

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available7
Approved for marketing4
Available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
U.S. Army Medical Research and Development Command2
Amgen1
Astellas Pharma Global Development, Inc.1
AstraZeneca1
Bayer1
BioMarin Pharmaceutical1
Bristol-Myers Squibb1
Eli Lilly and Company1
Janssen Research & Development, LLC1
Kite, A Gilead Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung2
Multiple Myeloma2
Bites and Stings1
Breast Neoplasms1
COVID-191
Carcinoma, Medullary1
Colonic Neoplasms1
Hypertension, Pulmonary1
Leukemia, Myeloid, Acute1
Lung Neoplasms1

Trials

Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.